Study Condition(s): Alzheimer's, Mild Cognitive Impairment

A Study of LY3303560 in Participants with Mild Cognitive Impairment or Alzheimer's Disease

Study Alias: LMDD

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT03019536 {{ currentLocaleObject.registryAnchorText }}

Recruiting Recruiting

Study Purpose

This study involves repeated doses of LY3303560 given by injection over 48 weeks. The study will examine how safe repeated doses of LY3303560 are, whether they cause side effects in participants with mild cognitive impairment or Alzheimer's Disease, and how LY3303560 is handled by the body and acts in the body.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria


Male Female


50+ years

Time Commitment

Your participation could last up to 18.5 months and include at least 27 visits to the study center
  • Participant must have Mild Cognitive Impairment (MCI) due to Alzheimer's Disease (AD) or mild-to-moderate AD
  • Female participant must not be of child-bearing potential
  • Participant must have a body weight of at least 50 kilogram (kg) or 110 pounds (lb)
  • Participant must be able to undergo Magnetic Resonance Imaging (MRI)
  • Part A participants must be willing to undergo a lumbar puncture (spinal tap)

Where to Participate

20 locations are currently available of 32 planned
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}} {{site.getSiteCTALabel() | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.